CDY Share Price

Open 0.03 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 6434159 1 Year 0.01 50.00
52 Week High 0.04
52 Week Low 0.02
CDY Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.03
Support 1 0.02
Support 2 0.02
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
AKK 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IMU 0.02 100.00%
IMU 0.02 100.00%
PMQ 0.03 50.00%
ARD 0.03 50.00%
ARD 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
EXG 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
SRX 16.00 -37.23%
SRX 16.00 -37.23%
More..

Cellmid Ltd (ASX: CDY)

CDY Technical Analysis 2
As on 9th Dec 2016 CDY Share Price closed @ 0.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
CDY Target for December
1st Target up-side 0.03
2nd Target up-side 0.03
3rd Target up-side 0.03
1st Target down-side 0.03
2nd Target down-side 0.03
3rd Target down-side 0.03
CDY Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.cellmid.com.au
CDY Address
CDY
Level 18
Suite 1802
Sydney, NSW 2000
Australia
Phone: 61 2 9221 6830
Fax: 61 2 9221 8535
CDY Latest News
Cellmid Ltd receives tax credit to bolster cash position   Proactive Investors Australia   - 30th Nov 16
Cellmid Ltd gets green light for patent in Europe   Proactive Investors Australia   - 22nd Sep 16
Cellmid Ltd: New research shows midkine antibody restores bone loss   Proactive Investors Australia   - 09th Aug 16
Cellmid Ltd to enter world's largest hair loss treatment market   Proactive Investors Australia   - 20th Jul 16
Cellmid Ltd's Maria Halasz talks revenue growth in Proactive Q&A Sessions™   Proactive Investors Australia   - 01st Jul 16
Cellmid Ltd completes world first study accelerating bone healing   Proactive Investors Australia   - 24th Jun 16
Cellmid Ltd delivers record sales revenue in Japan   Proactive Investors Australia   - 26th May 16
Cellmid Ltd to benefit from data at Budapest Midkine Symposium   Proactive Investors Australia   - 11th May 16
Cellmid Ltd progresses on road to commercialise midkine protein assets   Proactive Investors Australia   - 08th Apr 16
Cellmid Limited's CEO Maria Halasz buys shares on-market   Proactive Investors Australia   - 18th Dec 15
Interactive Technical Analysis Chart Cellmid Ltd ( CDY ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cellmid Ltd
CDY Business Profile
Cellmid Limited, a biotechnology company, is engaged in the development and commercialization of diagnostic and therapeutic products for heart attack, inflammatory diseases, and cancer in Australia. It offers MK ELISA, a sandwich enzyme immunoassay in a 96 well plate format for measuring MK levels in human serum samples. The company’s pipeline diagnostic programs include CAN104, a canine cancer diagnostic product, as well as CS5000 and CK3000, the cancer screening products; and CAMI103, a therapeutic program for heart attack, as well as CAB101, an anti-inflammatory antibody. It also develops and sells FGF-5, an over-the-counter treatment to alleviate excessive and abnormal hair loss and re-establish the natural hair growth cycle; and Évolis, a hair growth tonic for men and women. Cellmid Limited is based in Sydney, Australia.